How will I know if my Triple-Negative Breast Cancer treatment is working

How to Know If Your Triple-Negative Breast Cancer Treatment Is Working

This is one of the most important questions you can ask. Monitoring treatment response helps you and your oncology team make informed decisions about whether to continue, adjust, or change your approach.

Traditional Monitoring Methods

Imaging Studies (CT, MRI, PET scans) Your oncologist will typically use imaging at regular intervals—usually every 8-12 weeks during active treatment—to measure tumor size and look for new areas of cancer. According to NCCN Guidelines for breast cancer, imaging helps assess whether tumors are shrinking, staying stable, or growing.

However, there's an important limitation: imaging can only reliably detect tumors that are about 1 centimeter or larger (roughly a billion cancer cells). This means imaging may not catch very early signs of treatment failure or very early signs of response.

Emerging Monitoring Approaches: Liquid Biopsies

Beyond traditional imaging, newer blood-based tests called liquid biopsies are becoming increasingly valuable for monitoring treatment response in real-time.

Circulating Tumor Cells (CTCs) According to the CancerPatientLab webinar "Novel Testing to Guide Personalized Cancer Treatment," liquid biopsies can measure circulating tumor cells—cancer cells that have entered the bloodstream. These tests establish a baseline before treatment starts, then track changes over time:

• CTC numbers going DOWN = Treatment is working effectively
• CTC numbers staying the SAME = Treatment is having partial effect; may need adjustment or additional therapy
• CTC numbers going UP = Treatment may not be working; time to discuss changes with your team

The advantage? You can potentially detect treatment response or failure months earlier than imaging alone, giving you more time to make strategic decisions.

Stemness Markers These same liquid biopsies also measure "stemness markers"—indicators of how actively cancer cells are dividing and their potential to spread. You want to see these markers shift from positive to negative, showing reduced cancer activity.

Monitoring Schedule

According to the CancerPatientLab webinars on personalized cancer treatment, a typical monitoring approach involves:

• Every 3 months during active treatment with imaging and/or blood work
• Regular check-ins with your oncology team to review results
• Adjustments to treatment made at the earliest possible time if response is inadequate

Clinical Symptoms to Notice

While waiting for formal test results, pay attention to:

• Tumor size (if you can feel it)—is it getting smaller, staying the same, or growing?
• Pain levels—decreasing pain may suggest response
• Energy and overall function—improvement can indicate treatment is working
• New symptoms—appearance of new pain or swelling could suggest progression

Important Questions to Ask Your Oncology Team

1. What specific imaging or blood tests will you use to monitor my treatment?
2. How often will we do these tests, and when will we review the results together?
3. What specific measurements or markers indicate good response versus poor response for my case?
4. If imaging shows the tumor isn't shrinking, what are our next options?
5. Are there liquid biopsy tests (like CTC monitoring) available that might help us track response earlier?
6. At what point would you recommend changing treatment if the current approach isn't working?

The Bottom Line

For Triple-Negative Breast Cancer specifically, standard NCCN Guidelines recommend regular imaging assessment combined with clinical evaluation. However, emerging liquid biopsy technologies offer the potential for earlier detection of treatment response or failure, which is particularly valuable since you want to avoid spending time on ineffective treatments.

Your oncologist will determine the most appropriate monitoring approach for YOUR specific case, considering factors like your stage at diagnosis, the specific treatment you're receiving, and your overall health status.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.